Syndax Pharmaceuticals, Inc. · NASDAQ:SNDX

Vanguard Capital Management LLC reported a 5.05% stake in Syndax Pharmaceuticals, Inc. (Schedule 13G)

Event Mar 31, 2026 · Filed Apr 30, 2026

Vanguard Capital Management LLC reported a 5.05% stake in Syndax Pharmaceuticals, Inc., 4,457,143 shares, as a passive investor on Mar 31, 2026. Filed Apr 30, 2026 (Schedule 13G).

Stake
5.05%
Shares
4,457,143
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
Vanguard Capital Management5.05%4,457,143

Source

View original at SEC

Related